Press Releases ProKidney Corp.

Equities

PROK

KYG7S53R1049

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
3.71 ^USD	+10.09%		+10.09%	+108.43%

May. 28	Transcript : ProKidney Corp. - Special Call
May. 10	ProKidney Q1 Loss Unchanged From Year Earlier	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProKidney to Participate in the Jefferies Global Healthcare Conference	May. 29	AQ
ProKidney : Virtual KOL Presentation	May. 28	PU
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024	May. 21	AQ
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	May. 13	AQ
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	May. 10	AQ
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	Mar. 25	AQ
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights	Mar. 21	AQ
ProKidney to Participate in Jefferies Biotech on the Bay Summit	Feb. 29	AQ
Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments, Companies 2023 \| Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, Prokidney, and others.	Dec. 05	AQ
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer	Nov. 30	AQ
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference	Nov. 21	AQ
ProKidney Reports Third Quarter Financial Results	Nov. 14	AQ
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates	Nov. 13	AQ
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023	23-10-31	AQ
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023	23-10-30	AQ
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference	23-09-05	AQ
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights	23-08-10	AQ
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC	23-07-18	AQ
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization	23-07-17	AQ
PROKIDNEY CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-06-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ProKidney Corp.

Equities

PROK

KYG7S53R1049

Press Releases

Filters